BIOPALETTE Trademark

Trademark Overview


On Tuesday, January 9, 2018, a trademark application was filed for BIOPALETTE with the United States Patent and Trademark Office. The USPTO has given the BIOPALETTE trademark a serial number of 79242171. The federal status of this trademark filing is REGISTERED as of Wednesday, October 9, 2019. This trademark is owned by Bio Palette Co., Ltd.. The BIOPALETTE trademark is filed in the Chemical Products, Pharmaceutical Products, Natural Agricultural Products, and Computer & Software Services & Scientific Services categories with the following description:

Living cells, microorganisms, proteins, peptides, nucleic acid sequences, and combinations thereof for medical diagnosis or veterinary diagnosis purposes; pharmaceutical preparations produced by genome or gene editing operation for treatment of genetic diseases; pharmaceutical preparations produced by genome or gene editing operation for modifying human microbiome; chemical reagents for medical purposes produced by genome or gene editing operation; chemical reagents for medical purposes in the field of genome or gene editing operation; cultures of microorganisms for medical or veterinary use produced by genome or gene editing operation; living cells, microorganisms, proteins, peptides, nucleic acid sequences, and combinations thereof for medical or veterinary purposes produced by genome or gene editing operation; biological cells for surgical implantation produced by genome or gene editing operation; pharmaceutical and biological preparations, and diagnostic products based on gene, gen...

Chemicals for use in industry and science; chemical reagents for use in genetic research other than for medical or veterinary purposes; chemical reagents for use in genetic research in the field of genome or gene editing other than for medical or veterinary purposes; chemical substances produced by genome or gene editing operation for analyses in laboratories, other than for medical or veterinary purposes; chemical reagent for separation and production of gene editing substances for non-medical purposes; biotechnologically-formed genes for use in the manufacture of agricultural seeds produced by genome or gene editing operation; cultures of microorganisms produced by genome or gene editing operation, other than for medical or veterinary use; diagnostic reagents for scientific or research use in the field of genome or gene editing; biotechnologically-formed genes for use in the manufacture of agricultural seeds; cultures of microorganisms, other than for medical or veterinary use

Crop seeds; plant seeds; crop seeds produced by genome or gene editing operation; plant seeds produced by genome or gene editing operation; crop seeds in which herbicide tolerance genes are incorporated by genome or gene editing operation; plant seeds in which herbicide tolerance genes are incorporated by genome or gene editing operation; vegetable seeds for planting produced by genome or gene editing operation; seeds for agricultural purposes; vegetable seeds for planting; seeds for planting; genetically modified seeds including seeds for agricultural purposes, flower seeds, seeds for planting, or vegetable seeds for planting

Research and development in the field of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; scientific and technological services, namely, research and development, quality control, and technical advisory services relating thereto in the fields of protein, antibody, and microorganism study, and the study of cells; structural and functional analysis of the genome with genome editing technology; DNA screening for scientific research purposes with genome editing technology; scientific and technological services, namely, research, development, technical advisory services, and information technology services, all relating to genome editing technology; scientific and technological services, namely, research and development, quality control, and technical advisory services relating thereto in the fields of protein, antibody, and mi...
biopalette

General Information


Serial Number79242171
Word MarkBIOPALETTE
Filing DateTuesday, January 9, 2018
Status700 - REGISTERED
Status DateWednesday, October 9, 2019
Registration Number5778150
Registration DateTuesday, June 18, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2019

Trademark Statements


Amendment to a Registration/Renewal CertificateIn the Statement, " international Class 5 " is amended per the TTAB order dated 9/24/2020
Amendment to a Registration/Renewal CertificateIn the Statement, the following class 5 is updated per the Board Order dated July 23, 2020.
Goods and ServicesLiving cells, microorganisms, proteins, peptides, nucleic acid sequences, and combinations thereof for medical diagnosis or veterinary diagnosis purposes; pharmaceutical preparations produced by genome or gene editing operation for treatment of genetic diseases; pharmaceutical preparations produced by genome or gene editing operation for modifying human microbiome; chemical reagents for medical purposes produced by genome or gene editing operation; chemical reagents for medical purposes in the field of genome or gene editing operation; cultures of microorganisms for medical or veterinary use produced by genome or gene editing operation; living cells, microorganisms, proteins, peptides, nucleic acid sequences, and combinations thereof for medical or veterinary purposes produced by genome or gene editing operation; biological cells for surgical implantation produced by genome or gene editing operation; pharmaceutical and biological preparations, and diagnostic products based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy for use in treatment of genetic diseases; pharmaceutical and biological preparations, and diagnostic products based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy for use in treatment of cancer; pharmaceutical and biological preparations, and diagnostic products based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy for use in modifying human microbiome; cultures of microorganisms for medical or veterinary purposes; biological tissue cultures for medical or veterinary purposes * all of the foregoing [ other than those ] produced by genome or gene editing operation *
Goods and ServicesChemicals for use in industry and science; chemical reagents for use in genetic research other than for medical or veterinary purposes; chemical reagents for use in genetic research in the field of genome or gene editing other than for medical or veterinary purposes; chemical substances produced by genome or gene editing operation for analyses in laboratories, other than for medical or veterinary purposes; chemical reagent for separation and production of gene editing substances for non-medical purposes; biotechnologically-formed genes for use in the manufacture of agricultural seeds produced by genome or gene editing operation; cultures of microorganisms produced by genome or gene editing operation, other than for medical or veterinary use; diagnostic reagents for scientific or research use in the field of genome or gene editing; biotechnologically-formed genes for use in the manufacture of agricultural seeds; cultures of microorganisms, other than for medical or veterinary use
Goods and ServicesCrop seeds; plant seeds; crop seeds produced by genome or gene editing operation; plant seeds produced by genome or gene editing operation; crop seeds in which herbicide tolerance genes are incorporated by genome or gene editing operation; plant seeds in which herbicide tolerance genes are incorporated by genome or gene editing operation; vegetable seeds for planting produced by genome or gene editing operation; seeds for agricultural purposes; vegetable seeds for planting; seeds for planting; genetically modified seeds including seeds for agricultural purposes, flower seeds, seeds for planting, or vegetable seeds for planting
Goods and ServicesResearch and development in the field of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; scientific and technological services, namely, research and development, quality control, and technical advisory services relating thereto in the fields of protein, antibody, and microorganism study, and the study of cells; structural and functional analysis of the genome with genome editing technology; DNA screening for scientific research purposes with genome editing technology; scientific and technological services, namely, research, development, technical advisory services, and information technology services, all relating to genome editing technology; scientific and technological services, namely, research and development, quality control, and technical advisory services relating thereto in the fields of protein, antibody, and microorganism study, and the study of cells, all with genome editing technology; scientific research and development in the field of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems with genome editing technology; scientific research in the field of genetics and genetic engineering with genome editing technology; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs, all with genome editing technology; development of pharmaceuticals, cosmetics or foodstuffs, all with genome editing technology; technical advisory services relating to development of pharmaceuticals, cosmetics or foodstuffs, all with genome editing technology; information technology services relating to the development of pharmaceuticals, cosmetics or foodstuffs, all with genome editing technology; testing, inspection or research relating to medical treatment or medical technology with genome editing technology; information technology services for testing, inspection or research relating to medical treatment or medical technology with genome editing technology; testing or research relating to genome or gene to which genome editing technology is applied; scientific and medical research and survey in relation to bioinformatic tools in the fields of editing, modulation, modification, engineering, regulation, repair and therapy of gene, genome and cells to develop human pharmaceutical, biological preparations, and diagnostic products and services; scientific and technical research and development of bioinformatic tools in the fields of editing, modulation, modification, engineering, regulation, repair and therapy of gene, genome and cells to develop human pharmaceutical, biological preparations, and diagnostic products and services; research and development for the pharmaceutical industry and biotechnology industry with genome editing technology; research and development of biotechnology for others; research and development of genome editing technology for others; development of pharmaceutical preparations and medicines; biotechnology research; research and development in the field of genomics and biotechnology; technical advisory services in the field of genomics and biotechnology; structural and functional analysis of genomes; scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; scientific study and research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; design of bioinformatic algorithms and models for use in scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; laboratory research in the field of pharmaceuticals; conducting clinical trials for others in the field of pharmaceuticals; laboratory research in the field of gene expression; research and development services in the field of gene expression systems; research and development services in the field of microorganisms and cells; scientific research services in the field of genetic engineering relating to plants

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, October 10, 2018
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 10, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class031 - Agricultural, horticultural and forestry products and grains not included in other classes; live animals; fresh fruits and vegetables; seeds, natural plants and flowers; foodstuffs for animals; malt.
US Class Codes001, 046
Class Status Code6 - Active
Class Status DateWednesday, October 10, 2018
Primary Code031
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 10, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBio Palette Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameBio Palette Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHyogo 6570013
JP

Party NameBio Palette Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHyogo 6570013
JP

Trademark Events


Event DateEvent Description
Wednesday, October 10, 2018ASSIGNED TO EXAMINER
Thursday, October 4, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, October 10, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 16, 2018APPLICATION FILING RECEIPT MAILED
Tuesday, October 23, 2018NON-FINAL ACTION WRITTEN
Wednesday, October 24, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, November 7, 2018REFUSAL PROCESSED BY MPU
Wednesday, November 7, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, November 24, 2018REFUSAL PROCESSED BY IB
Friday, February 22, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 27, 2019ASSIGNED TO LIE
Wednesday, February 27, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 27, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 28, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 2, 2019PUBLISHED FOR OPPOSITION
Tuesday, June 18, 2019REGISTERED-PRINCIPAL REGISTER
Saturday, September 28, 2019FINAL DISPOSITION PROCESSED
Saturday, September 28, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 18, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, March 13, 2019NOTICE OF PUBLICATION
Wednesday, September 18, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, October 9, 2019CANCELLATION INSTITUTED NO. 999999
Wednesday, April 8, 2020TEAS SECTION 7 REQUEST RECEIVED
Thursday, July 23, 2020AMENDMENT UNDER SECTION 7 - PROCESSED
Tuesday, May 5, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, May 18, 2020POST REGISTRATION ACTION MAILED - SEC. 7
Monday, May 18, 2020REGISTERED - SEC. 7 REQUEST ABANDONED
Thursday, September 24, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 24, 2020CANCELLATION DENIED NO. 999999
Thursday, September 24, 2020AMENDMENT UNDER SECTION 7 - PROCESSED
Wednesday, September 30, 2020CANCELLATION TERMINATED NO. 999999
Wednesday, June 9, 2021INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Sunday, June 6, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Tuesday, June 18, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, July 30, 2022NEW REPRESENTATIVE AT IB RECEIVED
Saturday, March 18, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB